Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin

2007 ◽  
Vol 2007 ◽  
pp. 255-256
Author(s):  
G.A. Makar
2006 ◽  
Vol 130 (4) ◽  
pp. 1086-1097 ◽  
Author(s):  
Thomas Berg ◽  
Michael von Wagner ◽  
Samer Nasser ◽  
Christoph Sarrazin ◽  
Tobias Heintges ◽  
...  

2009 ◽  
Vol 51 (6) ◽  
pp. 325-329 ◽  
Author(s):  
Daniela Fernandes Cardoso ◽  
Fernando Vieira de Souza ◽  
Luiz Augusto M. Fonseca ◽  
Alberto José da Silva Duarte ◽  
Jorge Casseb

Hepatitis C virus (HCV) and human T-cell lymphotropic virus type 1 (HTLV-1) share routes of transmission and some individuals have dual infection. Although some studies point to a worse prognosis of hepatitis C virus in patients co-infected with HTLV-1, the interaction between these two infections is poorly understood. This study evaluated the influence of HTLV-1 infection on laboratory parameters in chronic HCV patients. Twelve HTLV-1/HCV-coinfected patients were compared to 23 patients infected only with HCV, in regard to demographic data, risk factors for viral acquisition, HCV genotype, presence of cirrhosis, T CD4+ and CD8+ cell counts and liver function tests. There was no difference in regard to age, gender, alcohol consumption, smoking habits, HCV genotype or presence of cirrhosis between the groups. Intravenous drug use was the most common risk factor among individuals co-infected with HTLV-1. These patients showed higher TCD8+ counts (p = 0.0159) and significantly lower median values of AST and ALT (p = 0.0437 and 0.0159, respectively). In conclusion, we have shown that HCV/HTLV-1 co-infected patients differs in laboratorial parameters involving both liver and immunological patterns. The meaning of these interactions in the natural history of these infections is a matter that deserves further studies.


2001 ◽  
Vol 184 (9) ◽  
pp. 1114-1119 ◽  
Author(s):  
Yasuhiro Kishihara ◽  
Norihiro Furusyo ◽  
Kenichiro Kashiwagi ◽  
Arahito Mitsutake ◽  
Seizaburo Kashiwagi ◽  
...  

2014 ◽  
Vol 30 (1) ◽  
pp. 97-101 ◽  
Author(s):  
Adele Caterino-de-Araujo ◽  
Mariana Cavalheiro Magri ◽  
Neuza Satomi Sato ◽  
Helena Kaminami Morimoto ◽  
Luis Fernando de Macedo Brigido ◽  
...  

2020 ◽  
Vol 19 (2) ◽  
pp. 166-171 ◽  
Author(s):  
Ricardo Henrique-Araújo ◽  
Lucas C. Quarantini ◽  
Mychelle Morais-de-Jesus ◽  
Ana Paula Jesus-Nunes ◽  
Adriana Dantas-Duarte ◽  
...  

2017 ◽  
Vol 91 (23) ◽  
Author(s):  
Sébastien Fauteux-Daniel ◽  
Ariane Larouche ◽  
Virginie Calderon ◽  
Jonathan Boulais ◽  
Chanel Béland ◽  
...  

ABSTRACT Hepatitis C virus (HCV) can be transmitted from mother to child during pregnancy and childbirth. However, the timing and precise biological mechanisms that are involved in this process are incompletely understood, as are the determinants that influence transmission of particular HCV variants. Here we report results of a longitudinal assessment of HCV quasispecies diversity and composition in 5 cases of vertical HCV transmission, including 3 women coinfected with human immunodeficiency virus type 1 (HIV-1). The population structure of HCV variant spectra based on E2 envelope gene sequences (nucleotide positions 1491 to 1787), including hypervariable regions 1 and 2, was characterized using next-generation sequencing and median-joining network analysis. Compatible with a loose transmission bottleneck, larger numbers of shared HCV variants were observed in the presence of maternal coinfection. Coalescent Bayesian Markov chain Monte Carlo simulations revealed median times of transmission between 24.9 weeks and 36.1 weeks of gestation, with some confidence intervals ranging into the 1st trimester, considerably earlier than previously thought. Using recombinant autologous HCV pseudoparticles, differences were uncovered in HCV-specific antibody responses between coinfected mothers and mothers infected with HCV alone, in whom generalized absence of neutralization was observed. Finally, shifts in HCV quasispecies composition were seen in children around 1 year of age, compatible with the disappearance of passively transferred maternal immunoglobulins and/or the development of HCV-specific humoral immunity. Taken together, these results provide insights into the timing, dynamics, and biologic mechanisms involved in vertical HCV transmission and inform preventative strategies. IMPORTANCE Although it is well established that hepatitis C virus (HCV) can be transmitted from mother to child, the manner and the moment at which transmission operates have been the subject of conjecture. By carrying out a detailed examination of viral sequences, we showed that transmission could take place comparatively early in pregnancy. In addition, we showed that when the mother also carried human immunodeficiency virus type 1 (HIV-1), many more HCV variants were shared between her and her child, suggesting that the mechanism and/or the route of transmission of HCV differed in the presence of coinfection with HIV-1. These results could explain why cesarean section is ineffective in preventing vertical HCV transmission and guide the development of interventions to avert pediatric HCV infection.


2020 ◽  
Vol 71 (16) ◽  
pp. 2233-2235 ◽  
Author(s):  
Juanjuan Zhao ◽  
Xuejiao Liao ◽  
Haiyan Wang ◽  
Lanlan Wei ◽  
Mingzhao Xing ◽  
...  

Abstract The effect of host immune status on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remains unknown. Here, we report the first case of coronavirus disease 2019 (COVID-19) with human immunodeficiency virus type 1 (HIV-1)/hepatitis C virus coinfection, who showed a persistently negative SARS-CoV-2 RNA test but delayed antibody response in the plasma. This case highlights the influence of HIV-1–induced immune dysfunction on early SARS-CoV-2 clearance.


Sign in / Sign up

Export Citation Format

Share Document